Elanco, NYSE and Animal Health

Elanco Animal Health Full Year 2024 Earnings: EPS Beats Expectations
Full Year 2024 Results Key Financial Results Revenue: US$4.44b (flat on FY
Elanco Animal Health Incorporated (NYSE:ELAN) Q4 2024 Earnings Call Transcript
Ladies and gentlemen, thank you for standing by. Welcome to Elanco Animal Health’s Fourth Quarter 2024 Earnings Conference Call. At this time, all lines have […]
Elanco Animal Health (NYSE:ELAN) Reaches New 1-Year Low on Disappointing Earnings
Elanco Animal Health Incorporated (NYSE:ELAN – Get Free Report) shares reached a new 52-week low during mid-day trading on Tuesday after the company announced weaker than expected quarterly earnings.
Elanco Animal Health Inc (ELAN) Q4 2024 Earnings Call Highlights: Strong Organic Growth and ...
Elanco Animal Health Inc (ELAN) reports robust organic growth and significant debt reduction, setting a positive outlook for 2025 despite foreign exchange challenges.
Elanco Animal Health 4Q Loss Narrows, Sales Decline
Elanco Animal Health narrowed its fourth-quarter loss despite lower sales, but its forecast for the current quarter and full year came in below Wall Street's estimates.
Elanco Animal Health (ELAN) to Release Earnings on Tuesday
Elanco Animal Health (NYSE:ELAN – Get Free Report) is anticipated to announce its earnings results before the market opens on Tuesday, February 25th. Analysts expect the company to announce earnings of $0.
Barclays Remains a Buy on Elanco Animal Health (ELAN)
In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Elanco Animal Health (ELAN – Research Report), with a price
CSR Wire14h
Elanco Enters Agreement With Medgene To Commercialize Highly Pathogenic Avian Influenza Vaccine in Dairy Cattle
Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has entered into an agreement with South Dakota-based ...
Elanco price target lowered to $15 from $16 at Stifel
Stifel analyst Jonathan Block lowered the firm’s price target on Elanco (ELAN) to $15 from $16 and keeps a Buy rating on the shares. While the ...
Elanco slips as forex headwinds weigh on outlook
Elanco Animal Health (NYSE:ELAN) stock falls as the company reports mixed Q4 2024 results, and sets 2025 outlook below consensus due to forex headwinds. Read more here.
Pharmabiz19h
Elanco Animal Health inks agreement with Medgene to commercialize highly pathogenic avian influenza vaccine in dairy cattle
Elanco Animal Health inks agreement with Medgene to commercialize highly pathogenic avian influenza vaccine in dairy cattle: Greenfield, Indiana Wednesday, February 26, 2025, 15:0 ...
Elanco price target lowered to $19 from $20 at Barclays
Barclays lowered the firm’s price target on Elanco (ELAN) to $19 from $20 and keeps an Overweight rating on the shares. The firm sees a “solid ...
Elanco Animal's Outlook Lags Street Expectations But Analyst Sees Time For Elanco's Commercial Investment To Payoff
Elanco Animal Health Incorporated (NYSE:ELAN) reported fourth-quarter revenue of $1.02 billion, a decrease of 1% on a ...